It is found that upregulation of FGF15-FGFR4 signaling accelerates the progression of nonalcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC) [43]. Here, FGFR4 is linked to metabolic dysfunction-associated steatotic liver disease.